PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy

SGG Vermeersch; J de Hoon; B De Saint-Hubert; I Derdelinckx; K Serdons; G Bormans; T Reynders; R Declercq; I De Lepeleire; W Kennedy; R Blanchard; E Marcantonio; R Hargreaves; CC Li; S Sanabria; E Hostetler; A Joshi; J Evelhoch; K Van Laere

Journal ArticleOPEN ACCESS

PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy

Vermeersch S
de Hoon J
De Saint-Hubert B
et al.

The Journal of Headache and Pain (2013) 14(S1)

DOI: 10.1186/1129-2377-14-s1-p224

N/ACitations

5Readers

Abstract

... anywhere at any time. Journal The Journal of Headache and Pain 14:P224 Online Date February 2013 DOI 10.1186 / 1129 - 2377 - 14 - S1 - P224 Print ISSN 1129-2369 Online ISSN 1129-2377 Publisher Springer Milan Additional Links: ...

Cite

CITATION STYLE

APA

Vermeersch, S., de Hoon, J., De Saint-Hubert, B., Derdelinckx, I., Serdons, K., Bormans, G., … Van Laere, K. (2013). PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy. The Journal of Headache and Pain, 14(S1). https://doi.org/10.1186/1129-2377-14-s1-p224

PET imaging in healthy subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy

Abstract

Cite

Register to see more suggestions